Examining the impact of the organizational immune system on strategic entrepreneurship in pharmaceutical companies: The mediating role of organizational innovation
Corporate and Business Strategy Review · 02.03.2026 · 7 (2) · 49
DOI: 10.22495/cbsrv7i2art5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Corporate and Business Strategy Review, online erschienen am 02.03.2026. Verfasst von Anas Al Tweijer und 1 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This investigation fills a significant knowledge gap by examining the impact of internal organizational procedures on strategic outcomes in ever-moving markets. In particular, the influence of the organizational immune system (OIS) on the accomplishment of organizational innovation (OI) and strategic entrepreneurship (SE). The study also focused on pharmaceutical businesses listed on the Amman Stock Exchange in Jordan to survey how OI intermediated the link between OIS and strategic business. A total of 181 individuals at the managerial level (including managers, representatives and subordinates) contributed to the survey. Partial least squares structural equation modeling (PLS-SEM) was used to analyze the data. It has been shown that both OI and SE are significantly influenced by the organization’s immune system. The results also showed that the link between OIS and SE was mediated by OI. This research is useful for organizations looking to be more entrepreneurial in their strategic approach, as it shows how an organization’s immune system can be used to drive innovation within the company, which in turn leads to long-term success.
Zitieren
APA
Tweijer, A. A., & Khasabah, M. A. I. A. (2026). Examining the impact of the organizational immune system on strategic entrepreneurship in pharmaceutical companies: The mediating role of organizational innovation. Corporate and Business Strategy Review, 7(2), 49. https://doi.org/10.22495/cbsrv7i2art5
Vancouver
Tweijer AA, Khasabah MAIA. Examining the impact of the organizational immune system on strategic entrepreneurship in pharmaceutical companies: The mediating role of organizational innovation. Corporate and Business Strategy Review. 2026;7(2):49. doi:10.22495/cbsrv7i2art5
BibTeX
@article{Tweijer2026,
author = {Tweijer, Anas Al and Khasabah, Mohammad Ali Ibrahim Al},
title = {Examining the impact of the organizational immune system on strategic entrepreneurship in pharmaceutical companies: The mediating role of organizational innovation},
journal = {Corporate and Business Strategy Review},
year = {2026},
volume = {7},
number = {2},
pages = {49},
doi = {10.22495/cbsrv7i2art5}
}
EUVIMED